Carl Pearson, MSES, PhD
Clinic Director for MMED '23, '24; Clinic Director for SEAMSFaculty Member, SEAMS, MMED, and DAIDD
Research Assistant Professor
University of North Carolina at Chapel Hill
North Carolina, USA
PhD in Physics, The George Washington University (2012)
MSES in Mechincal Engineering, The Naval Post Graduate School (2006)
BS in Mathematics & Physics, Duke University (2003)
About: Carl is a Research Fellow at the London School of Hygiene & Tropical Medicine, focusing on Ebola. He is also affiliated with SACEMA. He was a Faculty Observer at MMED 2015 and joined the Workshop Faculty in 2016.
Selected publications:
Pearson, Clifford, Pulliam, Eggo. (2021) Pre-vaccination testing could expand coverage of two-dose COVID vaccines. Wellcome Open Research
Pearson, van Schalkwyk, Foss, O’Reilly, SACEMA Modelling and Analysis Response Team, CMMID COVID-19 Working Group, Pulliam. (2020) Projected early spread of COVID-19 in Africa through 1 June 2020. Eurosurveillance
Pearson, Abbas, Clifford, Flasche, Hladish. (2019) Serostatus testing and dengue vaccine cost–benefit thresholds. Journal of the Royal Society Interface
Flasche, Jit, Rodríguez-Barraquer, Coudeville, Recker, Koelle, Milne, Hladish, Perkins, Cummings, Dorigatti, Laydon, España, Kelso, Longini, Lourenco, Pearson, Reiner, Mier-y-Terán-Romero, Vannice, Ferguson. (2017) The long-term safety, public health impact, and cost-effectiveness of routine vaccination with a recombinant, live-attenuated dengue vaccine (Dengvaxia) - a model comparison study. PLoS Medicine
Hladish, Pearson, Chao, Rojas, Recchia, Gómez-Dantés, M Halloran, Pulliam, Longini. (2016) Projected impact of dengue vaccination in Yucatán, Mexico. PLOS Neglected Tropical Diseases